In line with studies showing the impact of COX-2 on carcinogenesis, previous studies also described the effects of EP4 on carcinogenesis in several gynecological cancer models such as breast cancer [21,22], endometrial cancer [23,24], ovarian cancer [25] and cervical cancer [26]. Here, PTGS2 is linked to ovarian cancer.